Literature DB >> 19432553

Efavirenz treatment and false-positive results in benzodiazepine screening tests.

Antje Blank1, Victoria Hellstern, Dieter Schuster, Martin Hartmann, Anne K Matthée, Jürgen Burhenne, Walter E Haefeli, Gerd Mikus.   

Abstract

We investigated the effect of efavirenz treatment on the results of drug screening tests of urine samples obtained from 100 patients infected with human immunodeficiency virus. Of 50 patients who received efavirenz, 49 tested positive for benzodiazepines in > or =1 drug screening test, whereas of 50 patients who did not receive efavirenz, only 1 tested positive for benzodiazepines in > or =1 drug screening test. The major metabolite 8-hydroxy-efavirenz is responsible for this cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432553     DOI: 10.1086/599109

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

Review 1.  Efavirenz in the therapy of HIV infection.

Authors:  Natella Y Rakhmanina; John N van den Anker
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-01       Impact factor: 4.481

2.  2-Methyl-amino-5-nitro-benzoic acid.

Authors:  Abdul Rauf Raza; Syeda Laila Rubab; M Nawaz Tahir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-29

Review 3.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.